Chongqing Zhifei Biological Products A is a leading Chinese biotechnology company specializing in the research, development, production, and distribution of biological products and vaccines. The company makes a significant contribution to public health through innovative pharmaceutical solutions and high-quality vaccines for the global market.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Chongqing Zhifei Biological Products A is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Chongqing Zhifei Biological Products A last reported quarterly earnings on 8/28/2026 (Q2 2026). Earnings per share (EPS) came in at -0.18 CNY.
Across its last 3 earnings reports, Chongqing Zhifei Biological Products A stock moved by ±1.6% on average the following day. The largest reaction was -3.8% on 08/28/2026; 1 of 3 reactions were positive.
Chongqing Zhifei Biological Products A has beaten analyst EPS estimates in 0 of its last 5 evaluated quarters (beat rate: 0%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.